NO930226L - Cefalosporiner og homologer, fremstillinger og farmasoeytiske preparater - Google Patents
Cefalosporiner og homologer, fremstillinger og farmasoeytiske preparaterInfo
- Publication number
- NO930226L NO930226L NO93930226A NO930226A NO930226L NO 930226 L NO930226 L NO 930226L NO 93930226 A NO93930226 A NO 93930226A NO 930226 A NO930226 A NO 930226A NO 930226 L NO930226 L NO 930226L
- Authority
- NO
- Norway
- Prior art keywords
- preparations
- cephalosporins
- homologs
- pharmaceutical
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909016189A GB9016189D0 (en) | 1990-07-24 | 1990-07-24 | Novel compounds |
| GB919109540A GB9109540D0 (en) | 1991-05-02 | 1991-05-02 | Novel compounds |
| PCT/GB1991/001228 WO1992001696A1 (en) | 1990-07-24 | 1991-07-22 | Cephalosporins and homologues, preparations and pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO930226D0 NO930226D0 (no) | 1993-01-22 |
| NO930226L true NO930226L (no) | 1993-03-23 |
Family
ID=26297372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO93930226A NO930226L (no) | 1990-07-24 | 1993-01-22 | Cefalosporiner og homologer, fremstillinger og farmasoeytiske preparater |
Country Status (26)
| Country | Link |
|---|---|
| EP (2) | EP0540606A1 (no) |
| JP (2) | JP2851428B2 (no) |
| KR (1) | KR100189075B1 (no) |
| CN (2) | CN1061046C (no) |
| AP (1) | AP832A (no) |
| AT (1) | ATE185567T1 (no) |
| AU (1) | AU648329B2 (no) |
| CA (2) | CA2359744C (no) |
| CZ (1) | CZ6493A3 (no) |
| DE (2) | DE122006000065I2 (no) |
| DK (1) | DK0540609T3 (no) |
| ES (1) | ES2137162T3 (no) |
| FI (1) | FI930270A7 (no) |
| GR (1) | GR3031711T3 (no) |
| HU (1) | HUT63628A (no) |
| IE (1) | IE912569A1 (no) |
| IL (1) | IL98909A0 (no) |
| LU (1) | LU91290I2 (no) |
| MX (1) | MX9100317A (no) |
| MY (1) | MY106399A (no) |
| NL (1) | NL300249I2 (no) |
| NO (1) | NO930226L (no) |
| NZ (1) | NZ239061A (no) |
| PT (1) | PT98426A (no) |
| WO (2) | WO1992001696A1 (no) |
| YU (1) | YU129691A (no) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9125645D0 (en) * | 1991-12-03 | 1992-01-29 | Smithkline Beecham Plc | Novel compounds |
| JPH07503460A (ja) * | 1992-01-22 | 1995-04-13 | ファイザー・インコーポレイテッド | ２−イソセフェムおよびオキサセファム誘導体，それらの製法，その中間体および抗菌剤としての使用 |
| GB9212609D0 (en) * | 1992-06-13 | 1992-07-29 | Smithkline Beecham Plc | Novel compounds |
| GB9213567D0 (en) * | 1992-06-26 | 1992-08-12 | Smithkline Beecham Plc | Novel compounds |
| GB9424847D0 (en) * | 1994-12-09 | 1995-02-08 | Smithkline Beecham Plc | Novel process |
| GB2300856A (en) * | 1995-05-16 | 1996-11-20 | Pfizer Ltd | Beta-lactam preparation |
| AU4398297A (en) * | 1996-10-02 | 1998-04-24 | Daiichi Pharmaceutical Co., Ltd. | Method for esterifying carboxylic compounds |
| FR2776292B1 (fr) | 1998-03-20 | 2004-09-10 | Oncopharm | Cephalotaxanes porteurs de chaine laterale et leur procede de synthese |
| GB0019124D0 (en) | 2000-08-03 | 2000-09-27 | Pfizer | Novel process |
| ES2257471T3 (es) * | 2000-12-04 | 2006-08-01 | Pfizer Products Inc. | Procedimiento y derivados esteres utiles para la preparacion de cefalosporinas. |
| KR100526379B1 (ko) * | 2000-12-04 | 2005-11-08 | 화이자 프로덕츠 인크. | 세팔로스포린 제조에 유용한 커플링법 및 중간체 |
| US7378408B2 (en) * | 2001-11-30 | 2008-05-27 | Pfizer Inc. | Methods of treatment and formulations of cephalosporin |
| KR100710555B1 (ko) | 2001-12-04 | 2007-04-24 | 에스케이 주식회사 | 광학적으로 순수한 (ｒ)-폼 또는 (ｓ)-폼의테트라히드로퓨라닐 케톤의 제조방법 |
| UA117095C2 (uk) | 2011-12-22 | 2018-06-25 | Аліос Біофарма, Інк. | Нуклеозидна сполука або її фармацевтично прийнятна сіль |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| SG11201407336PA (en) | 2012-05-25 | 2015-03-30 | Janssen Sciences Ireland Uc | Uracyl spirooxetane nucleosides |
| KR102788773B1 (ko) | 2012-12-21 | 2025-03-28 | 얀센 바이오파마, 인코퍼레이트. | 치환된 뉴클레오사이드, 뉴클레오타이드 및 그것의 유사체 |
| CN105254648B (zh) * | 2015-11-13 | 2018-04-03 | 广东温氏大华农生物科技有限公司 | 一种头孢维星及其钠盐的合成方法 |
| GB2575261B (en) | 2018-07-02 | 2022-03-09 | Norbrook Lab Ltd | Intermediates in the synthesis of C3-substituted cephalosporins |
| SG11202101429YA (en) | 2018-08-23 | 2021-03-30 | Seagen Inc | Anti-tigit antibodies |
| BR112022010924A2 (pt) | 2019-12-06 | 2022-09-06 | Vertex Pharma | Tetra-hidrofuranos substituídos como moduladores de canais de sódio |
| CN115135383B (zh) | 2020-02-18 | 2024-06-11 | 吉利德科学公司 | 抗病毒化合物 |
| TWI874791B (zh) | 2020-02-18 | 2025-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| TWI883391B (zh) | 2020-02-18 | 2025-05-11 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| CN111620893B (zh) * | 2020-06-08 | 2021-12-14 | 重庆医药高等专科学校 | C-3位四氢呋喃取代的头孢菌素-铁载体耦合物及其制备方法和应用 |
| CA3216162A1 (en) | 2021-04-16 | 2022-10-20 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
| KR20240031300A (ko) | 2021-06-04 | 2024-03-07 | 버텍스 파마슈티칼스 인코포레이티드 | 나트륨 채널 조절제로서의 n-(하이드록시알킬 (헤테로)아릴) 테트라하이드로푸란 카르복스아미드 |
| CA3228162A1 (en) | 2021-08-18 | 2023-02-23 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
| CN121181574A (zh) * | 2025-11-24 | 2025-12-23 | 重庆汉佩生物科技有限公司 | 一种头孢维星衍生物和应用以及制备方法 |
| CN121181573A (zh) * | 2025-11-24 | 2025-12-23 | 重庆汉佩生物科技有限公司 | 一种含c-3位四氢呋喃头孢菌素衍生物和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE793448A (fr) * | 1971-12-31 | 1973-06-28 | Roussel Uclaf | Procede de preparation de nouveaux derives des cephalosporines et produits obtenus |
| FR2197573A1 (en) * | 1972-09-07 | 1974-03-29 | Roussel Uclaf | 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci |
| BE791161A (fr) * | 1972-01-03 | 1973-05-09 | Beecham Group Ltd | Procede pour la preparation d'analogues des cephalosporines |
| BE791160A (fr) * | 1972-01-03 | 1973-05-09 | Beecham Group Ltd | Nouveaux cephemes substitues |
| NL7305936A (no) * | 1972-05-05 | 1973-11-07 | ||
| JPS5849382A (ja) * | 1981-09-18 | 1983-03-23 | Kyowa Hakko Kogyo Co Ltd | β−ラクタム化合物 |
| GB8821797D0 (en) * | 1988-09-16 | 1988-10-19 | Beecham Group Plc | Novel compounds |
| ATE171705T1 (de) * | 1989-03-30 | 1998-10-15 | Pfizer | Cephalosporine und ihre homologen, verfahren zu ihrer herstellung und pharmazeutische präparate |
-
1991
- 1991-07-16 MY MYPI91001321A patent/MY106399A/en unknown
- 1991-07-22 WO PCT/GB1991/001228 patent/WO1992001696A1/en not_active Ceased
- 1991-07-22 EP EP91913545A patent/EP0540606A1/en not_active Withdrawn
- 1991-07-22 CA CA002359744A patent/CA2359744C/en not_active Expired - Lifetime
- 1991-07-22 AP APAP/P/1991/000305A patent/AP832A/en active
- 1991-07-22 DK DK91913583T patent/DK0540609T3/da active
- 1991-07-22 KR KR1019930700216A patent/KR100189075B1/ko not_active Expired - Lifetime
- 1991-07-22 FI FI930270A patent/FI930270A7/fi unknown
- 1991-07-22 AU AU82224/91A patent/AU648329B2/en not_active Expired
- 1991-07-22 WO PCT/GB1991/001227 patent/WO1992001695A1/en not_active Ceased
- 1991-07-22 NZ NZ239061A patent/NZ239061A/en not_active IP Right Cessation
- 1991-07-22 IE IE256991A patent/IE912569A1/en not_active IP Right Cessation
- 1991-07-22 EP EP91913583A patent/EP0540609B1/en not_active Expired - Lifetime
- 1991-07-22 MX MX9100317A patent/MX9100317A/es unknown
- 1991-07-22 DE DE200612000065 patent/DE122006000065I2/de active Active
- 1991-07-22 JP JP3512368A patent/JP2851428B2/ja not_active Expired - Lifetime
- 1991-07-22 AT AT91913583T patent/ATE185567T1/de active
- 1991-07-22 CZ CS9364A patent/CZ6493A3/cs unknown
- 1991-07-22 CA CA002087967A patent/CA2087967C/en not_active Expired - Lifetime
- 1991-07-22 ES ES91913583T patent/ES2137162T3/es not_active Expired - Lifetime
- 1991-07-22 JP JP3512255A patent/JPH05509089A/ja active Pending
- 1991-07-22 IL IL98909A patent/IL98909A0/xx unknown
- 1991-07-22 HU HU93177A patent/HUT63628A/hu unknown
- 1991-07-22 DE DE69131714T patent/DE69131714T2/de not_active Expired - Lifetime
- 1991-07-23 PT PT98426A patent/PT98426A/pt not_active Application Discontinuation
- 1991-07-23 YU YU129691A patent/YU129691A/sh unknown
- 1991-07-24 CN CN91105783A patent/CN1061046C/zh not_active Expired - Lifetime
-
1993
- 1993-01-22 NO NO93930226A patent/NO930226L/no unknown
-
1998
- 1998-11-14 CN CN98122407A patent/CN1111410C/zh not_active Expired - Lifetime
-
1999
- 1999-11-03 GR GR990402803T patent/GR3031711T3/el unknown
-
2006
- 2006-11-22 LU LU91290C patent/LU91290I2/fr unknown
- 2006-11-27 NL NL300249C patent/NL300249I2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0540609T3 (da) | Cephalosporiner og homologer, fremstillinger og farmaceutiske præparater | |
| FI924340L (fi) | Farmaceutiska beredningar | |
| IS3720A7 (is) | Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun | |
| NO943511D0 (no) | Farmasöytiske preparater og anvendelse derav | |
| DK0527879T3 (da) | Synergistiske terapeutiske præparater og fremgangsmåder. | |
| NO902658D0 (no) | N-fenylpyrazolderivater, preparater og anvendelse derav. | |
| NO921012D0 (no) | Farmasoeytiske preparater og deres anvendelse | |
| FI912952L (fi) | Kontrollerbart frigoerande farmaceutiskt preparat. | |
| NO894228D0 (no) | Tienopyridiner, fremstilling, mellomprodukter og farmasoeytiske preparater. | |
| NO922005D0 (no) | Farmasoeytiske preparater | |
| FI911986L (fi) | Farmaceutiska foereningar. | |
| FI922785A7 (fi) | Terapeuttisia valmisteita | |
| NO922506D0 (no) | Farmasoeytiske preparat | |
| FI924551A7 (fi) | Farmaceutiska foereningar | |
| NO910003L (no) | Vitamin e-derivater og fremgangsmaate for deres fremstilling. | |
| FI913100A7 (fi) | Farmaseuttiset valmisteet | |
| NO304890B1 (no) | Farmas°ytiske forbindelser og farmas°ytiske preparater | |
| DK650089A (da) | Furanalkylketoner og farmaceutiske praeparater deraf | |
| FI921877L (fi) | Farmaceutiska foereningar | |
| NO911047D0 (no) | Labdaner og fremgangsmaate for deres fremstilling. | |
| NO912946D0 (no) | P-acylaminofenoksikarbamater og derivater. | |
| NO903675D0 (no) | Aminfrie forestrede glycidyleter-addisjonsprodukter og anvendelse derav. | |
| NO911298D0 (no) | Farmasoeytisk preparat og anvendelse derav. | |
| NO179907C (no) | Benzokinoksaliner og farmasöytiske preparater inneholdende de samme | |
| NO901052D0 (no) | 1h-pyrazol-1-acetamider og fremstilling derav. |